Reason and rights in global drug control policy

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 5, 2005, Pages 655-656

  Elliott, Richard ^c,d   Csete, Joanne ^c,d   Palepu, Anita ^b   Kerr, Thomas ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Canadian HIV/AIDS Legal Network   (Canada)

^d Canadian HIV/AIDS Legal Network   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANADA; DRUG CONTROL; EVIDENCE BASED MEDICINE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION CONTROL; NOTE; POLICY;

EID: 14844303923     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050115     Document Type: Note

References (32)

1. Wolfe D, Malinowska-Sempruch K. Illicit drug policies and the global HIV epidemic: effects of UN and national government approaches. A working paper commissioned by the HIV/AIDS Task Force of the Millennium Project. New York: Open Society Institute; 2004.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic 2004: 4tb global report. Geneva: UNAIDS; 2004.
3. Kerr T, Wodak A, Elliott R, Montaner JS, Wood E. Opioid substitution and HIV/AIDS treatment and prevention. Lancet 2004;364:1918-9.
4. Aceijas C, Stimson GV, Hickman M, Rhodes T, United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004;18(17):2295-303.
5. World Health Organization. Management of substance abuse: WHO drug injection study. Geneva: WHO; 2003.
6. Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS epidemic Update: December 2003. Geneva: UNAIDS; 2003.
7. Rhodes T, Sarang A, Bobrik A, Bobkov E, Platt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy 2004;15:1-16.
8. Wodak A, Ali R, Farrell M. HIV in injecting drug users in Asian countries. BMJ 2004;32:697-8.
9. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the Global HIV/AIDS Epidemic 2002. Geneva: UNAIDS; 2002.
10. World Health Organization (WHO). Scaling up antiretroviral therapy in resource-limited setting: treatment guidelines for a public health approach. 2003 revision. Geneva: WHO; 2004.
11. Breaking down barriers: lessons on providing HIV treatment to injection drug users. New York: Open Society Institute; 2004.
12. Central and Eastern European Harm Reduction Network (CEEHRN). Injecting drug users, HIV/AIDS treatment and primary care in Central and Eastern Europe and the former Soviet Union: Results of a region-wide survey. Vilnius: CEEHRN; 2002.
13. Gowing L, Farrell M, Bornemann R, Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection [Cochrane review]. In: The Cochrane Library (Issue 4). Chichester (UK): John Wiley & Sons, Ltd.; 2004.
14. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998;280:547-9.
15. Wood E, Montaner JS, Bangsberg D, Tyndall MW, Strathdee SA, O'Shaughnessy MV, et al. Expanding access to HIV antiretroviral therapy to marginalized populations in the developed world. AIDS 2003;17:2419-27.
16. Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001;15:1707-15.
17. Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS 2000;14:151-5.
18. Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med 2003;18:248-57.
19. Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and substance use problems: the impact of substance abuse treatment. Addiction 2004;99:361-8.
20. Wall TL, Sorensen JL, Batki SL, Deluchi KL, London JA, Chesney MA. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Depend 1995;37:261.
21. World Health Organization, UN Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention [position paper]. Geneva: WHO; 2004: Abstract available: www.who.mt/substance_abuse /publications/en/PositionPaper_flyer_English.pdf (accessed 2005 Feb 1).
22. Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: responses in developing and transitional countries [review]. Public Health Rep 1998;113(suppl 1):170-81.
23. World Health Organization. Essential medicines: WHO model list (revised April 2003). 13th ed. Geneva: WHO; 2003. Available at: www.who.int/medicines /organization/par/edl/expcom13/eml13_en.pdf (accessed 2005 Feb 1).
24. Kerr T, Wodak A, Elliott R, Montaner JS, Wood E. Opioid substitution and HIV/AIDS treatment and prevention. Lancet 2004;364:1918-9.
25. Charter of the United Nations, 26 June 1945 (entered into force 24 October 1945), T.S. 993, Articles 55 & 56.
26. Universal Declaration of Human Rights, UN General Assembly res. 217A (III), UN Doc A/810 at 71 (1948), Article 25.
27. 993 U.N.T.S. 3, entered into force 3 January 1976.
28. United States of America. "Thematic Topic: HIV/AIDS in the Context of Drug Use," paper for Intersessional Working Group on Thematic Drug (2nd meeting, 20 October 2004) regarding UN Commission on Narcotic Drugs, 48th Session (2005), on file with the authors.
29. Canada in the world: Canadian foreign policy review. Ottawa: Department of Foreign Affairs and International Trade; 1995: Available at: www.dfait-maeci.gc.ca/foreign_policy/cnd-world/menu-en.asp (accessed 2005 Feb 1).
30. A dialogue on foreign policy: a report to Canadians. Ottawa: Department of Foreign Affairs and International Trade; 2003. Available at: www.dfait-maeci.gc.ca/cip-pic/participate/dialoguereport-en.asp (accessed 2005 Feb 1).
31. Canada's Drug Strategy. Ottawa: Health Canada; 1998. Available at: www.hc-sc.gc.ca/hecs-sesc/cds/pdf/englishstrategy.pdf (accessed 2005 Feb 1).
32. Reducing the harm associated with injection drug use in Canada. Report prepared by the Federal/Provincial/Territorial Advisory Committees on Population Health, Alcohol and Other Drug Issues, AIDS, and the Federal/Provincial/ Territorial Heads of Corrections Working Group on HIV/AIDS, 2001 Available at: www .hc-sc.gc.ca/hecs-sesc/cds/pdf/injectiondrug_e.pdf (accessed 2005 Feb 1).